Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange
NBER Working Paper No. 18359
---- Acknowledgements ----
Portions of this paper previously circulated as "Market Design When Firms Interact with Inertial Consumers: Evidence from Medicare Part D." I thank Martin Andersen, Raj Chetty, David Cutler, Stefano DellaVigna, Drew Fudenberg, Andreas Fuster, Larry Katz, David Laibson, Michael Grubb, Oliver Hart, Dan McFadden, Tom McGuire, Jim Rebitzer, and Amanda Starc for their thoughtful comments. I thank the Williams College Tyng Committee and the National Science Foundation for research support. I have no further disclosures. The views expressed herein are those of the author and do not necessarily reflect the views of the National Bureau of Economic Research.